THE USE EXPERIENCE OF CRIZOTINIB (XALKORI (R)) FOR POSTOPERATIVE RECURRENCE OF ALK-REARRANGED NON-SMALL CELL LUNG CANCER
JOURNAL OF THORACIC ONCOLOGY（2013）
Key words
Lung cancer,Crizotinib,ALK,XALKORI
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined